Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vijay R. Prabhakar
Observed names:
V. R. Prabhakar,
Vijay K. Prabhakar,
Vijay Prabhakar,
Vijay R Prabhakar
Institution:
Boehringer Ingelheim (United States)
Observed institutions:
University of Southern California,
Duke University,
Dr. Reddy's Laboratories (India),
Duke Medical Center,
Stanford Medicine,
Boehringer Ingelheim (United States),
Stanford University
show all 7
OpenAlex ID:
A5111456002
Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses
2019
·
Min-Nung Huang
, Lowell T. Nicholson
, et al.
·
Journal of Clinical Investigation
·
68
Heart-targeted overexpression of Nip3a in zebrafish embryos causes abnormal heart development and cardiac dysfunction
2006
·
Wen-Der Wang
, Chang-Jen Huang
, et al.
·
Biochemical and Biophysical Research Communications
·
16
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non–Hepatocellular Carcinoma Factors
2020
·
Nia Adeniji
, Vinodhini Arjunan
, et al.
·
Liver Transplantation
·
10
Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post‐transplant Clinical Outcome
2020
·
Nia Adeniji
, Vinodhini Arjunan
, et al.
·
Clinical Transplantation
·
8
PDF
Blood Pressure Monitoring in Clinical Trials in the Absence of Ambulatory Blood Pressure Recording: Where Is the Stand?
2005
·
Vijay R. Prabhakar
·
Hypertension
·
8
Toward Elimination of Hepatitis C Infection: How Best to Address Gaps in the Cascade of Care?
2019
·
Vijay Prabhakar
, Paul Y. Kwo
·
Hepatology Communications
·
4
PDF
Milk casein and its benefits on cardiovascular risk
2007
·
V. R. Prabhakar
, N. Venkatesan
·
European Heart Journal
·
4
A Case of Difficult Diagnosis of Rabies in the Absence of a Dog Bite in a Patient With Depression
2006
·
V. R. Prabhakar
, R.N. Monsy Abraham
·
Journal of Neuropsychiatry
·
2
Potential of Artificial Intelligence in Improving Speed and Efficiency of Clinical Trials
2024
·
Vijay R. Prabhakar
·
SBV Journal of Basic Clinical and Applied Health Science
·
1
Is ribavirin alive or dead in the current era of HCV therapy?
2020
·
Vijay Prabhakar
, Paul Y. Kwo
953 Sustained Decline of Noninvasive Fibrosis Index Values in Patients With Chronic Hepatitis C (CHC) With Sustained Virologic Response (SVR) After Receiving Direct-Acting Antiviral Agents (DAAs)
2019
·
Vijay Prabhakar
, Glen Lutchman
, et al.
·
The American Journal of Gastroenterology
Dual antigen transfer pathways mediate highly efficacious anti-tumor immunity induced by intravenously injected antigen-loaded monocytes
2017
·
Min-Nung Huang
, Lowell Nicholson
, et al.
·
The Journal of Immunology
Global Development of Biosimilars: Opportunities for Asia Pacific
2009
·
Vijay Prabhakar
, Pablo Tomas Fernández
·
Australasian biotechnology
Role of Potential Immune Targets in Atherosclerosis for Vaccine Development
2008
·
Nandini Venkatesan
, Vijay R. Prabhakar
·
Preventive Cardiology
PDF
Neuroacanthocytosis: Presenting With Depression
2006
·
Vijay Prabhakar
Lipid levels and coronary heart disease: need for region-specific guidelines.
2005
·
Vijay R Prabhakar
·
PubMed
Lick the Stomach and Bite the Heart?
2005
·
Vijay R. Prabhakar
·
Heart Drug
Can Statins Be Considered as a Tertiary Level Agent in Patients with Failure of Conventional Oral Hypoglycemic Agents?
2005
·
Vijay Prabhakar
, P.V. Krishna Kishore
, et al.
·
Heart Drug
Contents Vol. 5, 2005
2005
·
Jens Kastrup
, Vijay Prabhakar
, et al.
·
Heart Drug
PDF
Subject Index Vol. 5, 2005
2005
·
Jens Kastrup
, Vijay Prabhakar
, et al.
·
Heart Drug
PDF
Congress Calendar
2005
·
Peter Christian Burger
, Andreina Schoeberlein
, et al.
·
Heart Drug
Show more works
View as search
Works count:
21
Citation count:
121
H-index:
5
I10-index:
3
Year
Topic
Type
